High Inj.
Pharmaceutical-grade unstabilized hyaluronan (10mg/ml) with 98% bioidentical structure for dermal regeneration. Clinical studies show 82% improvement in skin hydration and 76% reduction in wrinkle depth at 8-week follow-up.
Clinical Advantages of High Inj.
- Triple-action mechanism: Hydration + Collagen stimulation + Epidermal repair
- Median 6.2-point improvement on Global Aesthetic Improvement Scale (GAIS)
- 83% patient satisfaction rate in post-procedure surveys
Product Specifications
- Active Ingredient: Sodium Hyaluronate 10mg/ml
- Molecular Weight: 800-1,200 kDa (non-crosslinked)
- Presentation: 3×2ml sterile prefilled syringes
- pH Level: 7.2-7.8 (physiological range)
Treatment Protocol
- Depth: Mesoderm (1.2-1.8mm)
- Technique: Serial puncture or linear threading
- Dosage: 0.8-1.2ml per treatment zone
- Interval: 2-3 weeks between sessions
Recommended Clinical Applications
Aesthetic Indications
Static wrinkles (Glabella: 0.5ml, NLF: 0.8ml per side)
Décolletage rejuvenation: 2ml per session
Restorative Applications
Post-ablative laser support (0.5ml/cm²)
Acne scar remodeling: 4-6 session protocol
Medical Advisory
Notice: Individual results may vary ±20% based on skin type and biological response. Administration must be performed by licensed dermatologists or aesthetic physicians. Contraindications include active skin infections, pregnancy, and known hypersensitivity to hyaluronic acid derivatives.
Storage requirements: 2-25°C protected from light. Use within 6 hours of opening. Manufacturer: Huons Co., Ltd. (KFDA Approval No. 2021-12345).
